Related Experiment Video

Updated: Aug 16, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Cardiorenal disease: a clinical intersection

Vikram Kalra1, Sandeep Mahajan, Sanjay Kumar Agarwal

  • 1Department of Nephrology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India. docvikramkalra@rediffmail.com

International Urology and Nephrology
|September 1, 2005
PubMed

Insights

Renal insufficiency significantly increases cardiovascular disease risk, even with minor kidney dysfunction. Treatments like ACE inhibitors and statins can help, but more research is needed on prevention.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Chronic renal insufficiency is linked to increased cardiovascular disease (CVD) risk.
  • Even mild kidney dysfunction independently predicts atherosclerotic CVD.
  • This association is critical given the rising prevalence of renal dysfunction.

Purpose of the Study:

  • To review the association between renal insufficiency and cardiovascular disease.
  • To discuss current and potential therapeutic options for this high-risk population.

Main Methods:

  • Literature review of studies examining renal function and cardiovascular outcomes.
  • Analysis of therapeutic interventions for patients with renal insufficiency and CVD.

Main Results:

  • Minor renal dysfunction is an independent risk factor for atherosclerotic CVD.
  • Angiotensin-converting enzyme inhibitors and statins reduce cardiovascular morbidity and mortality.
  • Coronary revascularization improves prognosis but is underutilized in patients with renal insufficiency.
  • Percutaneous transluminal coronary angioplasty carries high mortality in patients with reduced renal function.

Conclusions:

  • Renal insufficiency poses a significant cardiovascular risk that requires further investigation.
  • Preventive strategies and optimized interventions are crucial for managing cardiovascular risk in patients with declining kidney function.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...